ArticleSignal transduction and targeted therapy2026
Source-specific priming of lung NK cells by Pseudomonas LPS enhances resistance to bacterial pneumonia.
Article in Signal transduction and targeted therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
Bacterial pneumonia is a major cause of morbidity and mortality in elderly individuals, yet how mucosal innate immunity changes with age remains unclear. We detected bacterial DNA, particularly signatures of Pseudomonas, in the circulation of healthy elderly individuals, suggesting that chronic exposure to low-dose microbial components occurs during aging. Using murine models, we found that intratracheal delivery of a low dose of Pseudomonas aeruginosa lipopolysaccharide (LPS) strongly protected against bacterial pneumonia through a microbiota-dependent mechanism, whereas Escherichia coli LPS had no detectable protective effect. This protective response occurred in the absence of adaptive immunity and was mediated by lung-resident natural killer (NK) cells. Transcriptomic profiling revealed that P. aeruginosa LPS selectively upregulated the complement receptor C3aR1 in pulmonary NK cells, increasing their IFN-γ production and LFA-1-dependent adhesion to target cells. Adoptive transfer of P. aeruginosa LPS-conditioned pulmonary NK cells conferred protection to naïve recipients, whereas silencing C3aR1 abrogated this effect. This localized innate training occurred without systemic inflammation and required the presence of a commensal microbiota. These findings reveal that structurally distinct LPS from P. aeruginosa programs lung NK cells toward a C3aR1-driven, high-affinity effector state that enhances resistance to bacterial pneumonia. Source-specific innate conditioning of mucosal NK cells may provide a tissue-targeted strategy to strengthen pulmonary host defense, particularly in aging populations vulnerable to respiratory infections.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.